Total Funding
77
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
115232
XCR Diagnostics is a developing and delivering a simple, easy to use system to the molecular diagnostic near patient testing market.
- Brian Caplin: Chief Scientific OfficerPast Role: Fluoresentric, Founder & Chief Scientific Officer
Mark Powelson: Founder ,CEO & President
About the Company
XCR Diagnostics is a developing and delivering a simple, easy to use system to the molecular diagnostic near patient testing market.XCR Diagnostics started with the patented XCR® chemistry and initially developed a hand-held instrument around our XCR® chemistry that utilized the camera on a mobile telephone to detect fluorescence signal generated
via amplification in real time. Our latest generation system, a portable bench-top system, can accurately detect pathogens from clinical specimens in as few as 7 minutes. We are in the process of developing test units of our Pyramid, portable Nucleic Acid Testing System for an upcoming FDA Clinical Trial and CE-IVD marking.
